Off-Label Letermovir Use in Solid Organ Transplant Recipients at a Large Academic Medical Center (WTC 2025) - Jul 30, 2025 - Abstract #P2.12.19; Pres time: Aug 4, 2025; 03:30 PM - 04:30 PM; Location: Exhibit Hall AB; "Off-label LTM use within our institution was widespread and most commonly used as alternative PPX for SOTR experiencing cytopenias. LTM was well tolerated, with low rates of CMV breakthrough. SOTR demonstrated a need for tacrolimus dose adjustments."
Clinical • Cytomegalovirus Infection • Hematological Disorders • Solid Organ Transplantation • Transplantation
|
|
A. Matsikas 1; M. Ali 1; F. Zervou 2; S. Mehta 2; S. Jonchhe 2
|